Emerging Anesthetic Nanomedicines: Current State and Challenges
Shuo Zhang,Yishu Wang,Shuai Zhang,Chengqi Huang,Qiyang Ding,Ji Xia,Daocheng Wu,Wei Gao
DOI: https://doi.org/10.2147/ijn.s417855
IF: 7.033
2023-07-19
International Journal of Nanomedicine
Abstract:Shuo Zhang, 1, &ast Yishu Wang, 1, &ast Shuai Zhang, 1 Chengqi Huang, 1 Qiyang Ding, 2 Ji Xia, 2 Daocheng Wu, 1 Wei Gao 2 1 The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China; 2 Department of Anesthesiology & Center for Brain Science & Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China &astThese authors contributed equally to this work Correspondence: Daocheng Wu, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China, Tel/Fax +86-29-82663941, Email Wei Gao, Department of Anesthesiology & Center for Brain Science & Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China, Tel +86 15209225834, Email Anesthetics, which include both local and general varieties, are a unique class of drugs widely utilized in clinical surgery to alleviate pain and promote relaxation in patients. Although numerous anesthetics and their traditional formulations are available in the market, only a select few exhibit excellent anesthetic properties that meet clinical requirements. The main challenges are the potential toxic and adverse effects of anesthetics, as well as the presence of the blood-brain barrier (BBB), which makes it difficult for most general anesthetics to effectively penetrate to the brain. Loading anesthetics onto nanocarriers as anesthetic nanomedicines might address these challenges and improve anesthesia effectiveness, reduce toxic and adverse effects, while significantly enhance the efficiency of general anesthetics passing through the BBB. Consequently, anesthetic nanomedicines play a crucial role in the field of anesthesia. Despite their significance, research on anesthetic nanomedicines is still in its infancy, especially when compared to other types of nanomedicines in terms of depth and breadth. Although local anesthetic nanomedicines have received considerable attention and essentially meet clinical needs, there are few reported instances of nanomedicines for general anesthetics. Given the extensive usage of anesthetics and the many of them need for improved performance, emerging anesthetic nanomedicines face both unparalleled opportunities and considerable challenges in terms of theory and technology. Thus, a comprehensive summary with systematic analyses of anesthetic nanomedicines is urgently required. This review provides a comprehensive summary of the classification, properties, and research status of anesthetic nanomedicines, along with an exploration of their opportunities and challenges. In addition, future research directions and development prospects are discussed. It is hoped that researchers from diverse disciplines will collaborate to study anesthetic nanomedicines and develop them as a valuable anesthetic dosage form for clinical surgery. Keywords: anesthesia, nanocarriers, blood-brain barrier, drugs The modern era of anesthetic medicines was pioneered by William T.G. Morton, an American dentist who, in 1846, successfully demonstrated the use of medical anesthesia with diethyl ether through inhalation, marking a significant turning point in surgical procedures. Since then, anesthetics have transformed surgery from a terrifying and agonizing experience to a painless and peaceful process, saving countless lives worldwide each year. As a result, anesthetics have become a crucial class of drugs used in clinical surgery. 1 Anesthesia typically involves the temporary inhibition of central and/or peripheral nervous system function through oral, inhalational, topical, intravenous, or intramuscular anesthetics. Electromyography studies have shown that anesthetics temporarily and reversibly disrupt the connections between cortical and thalamic neurons. This results in the absence of pain sensation, even during invasive procedures involving certain body tissue owing to the effects of the anesthetics. 2 As new medicines, biotechnologies, innovations, and drug discoveries emerge, the development of anesthetics has continued to make significant progress. In clinical practice, anesthetics are currently divided into two main categories of local anesthesia and general anesthesia, with related anesthetics also falling under these categories as local and general anesthetics. 3 Local anesthesia involves the temporary numbing of a specific area of the body, typically used for minor sur -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology